- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
Pharma Companies Align for New Industry Standards Group
January 11, 2017
Six of the top global pharma companies - Allergan, AstraZeneca, Biogen, GSK, Novartis, and Pfizer - have partnered with Veeva Systems, formed Align Biopharma, a new group "dedicated to setting standards that will make it faster and easier for healthcare professionals (HCPs) to connect with the life sciences industry."
The founding members will develop open standards and solutions for companies to streamline how HCPs get the drug and treatment information they need to deliver improved care to patients.
Initially, Align Biopharma will focus on developing two new standards to facilitate seamless digital engagement and simplify the HCP experience: identity management and consent and communication preferences.
Patrick Retif, VP IT, Global Commercial at Allergan, commented: “Common industry standards can make it more effective and efficient for pharma companies and healthcare professionals to connect. Working together can help harmonize digital engagement and information access across the industry and create a better experience for our shared customers.”
For more information, visit AlignBiopharma.org
